by ASTCT Talks
Welcome to the first installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US.
by Dr. Corey Cutler, MD, MPH
In the October President's Message, Dr. Corey Cutler, MD, MPH, reflects on the impactful moments from the recent Clinical Education Conference in Saint Louis, where transplant and cell therapy...
by Nature
Researchers believe treatment with an antibacterial enzyme specific to Enterococcus faecalis may provide prophylaxis against acute graft-versus-host disease (aGVHD).
by ImmonuoHorizons
Researchers have identified a promising new platform for preclinical testing of chimeric antigen receptor (CAR) T cell efficacy against solid tumors.
by Blood Advances
Early evidence supports a deeper look into candidate chimeric antigen receptor (CAR) T-cell therapies for the treatment of relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL) in...
by Blood Advances
Although HLA-matched sibling donors (MSDs) are considered the gold standard for hematopoietic cell transplantation (HCT), evidence suggests comparable outcomes are possible with haploidential...